Insider Buying: International Biotechnology Trust plc (LON:IBT) Insider Buys 1,500 Shares of Stock

International Biotechnology Trust plc (LON:IBT) insider Katherine Cornish-Bowden purchased 1,500 shares of the business’s stock in a transaction dated Wednesday, January 12th. The shares were acquired at an average price of GBX 684 ($9.28) per share, for a total transaction of £10,260 ($13,926.97).

International Biotechnology Trust stock opened at GBX 660 ($8.96) on Friday. International Biotechnology Trust plc has a 12 month low of GBX 651.42 ($8.84) and a 12 month high of GBX 862 ($11.70). The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 2.89. The business has a 50 day moving average price of GBX 732.03 and a two-hundred day moving average price of GBX 729.83. The stock has a market cap of £271.72 million and a price-to-earnings ratio of 4.08.

The business also recently announced a dividend, which will be paid on Friday, January 28th. Stockholders of record on Thursday, December 30th will be issued a GBX 15.70 ($0.21) dividend. The ex-dividend date of this dividend is Thursday, December 30th. This is a boost from International Biotechnology Trust’s previous dividend of $14.20. This represents a dividend yield of 2.14%. International Biotechnology Trust’s dividend payout ratio is presently 0.18%.

Separately, Barclays restated an “overweight” rating and set a GBX 260 ($3.53) price target on shares of International Biotechnology Trust in a report on Thursday, November 18th.

About International Biotechnology Trust

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.

Recommended Story: Why do companies issue convertible shares?

Receive News & Ratings for International Biotechnology Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology Trust and related companies with's FREE daily email newsletter.